Skip to main content
Log in

Histopathological parameters as predictors for the course of Crohn's disease

  • Original Article
  • Published:
Virchows Archiv Aims and scope Submit manuscript

Abstract

Background

Recent classification systems discriminate penetrating Crohn's disease (CD) from stricturing and non-stricturing/non-penetrating CD. As yet, no easily detectable marker is known that can predict the course of CD. Individual, clinical course-specific new treatment schemes would be highly desirable for different potentially divergent pathophysiological pathways (e.g., fistula vs stenosis).

Methods

Intestinal tissue biopsies from 63 CD patients with a disease follow-up of up to 7 years were studied retrospectively. In biopsy specimens, 34 histopathological features present prior to the onset of (a) strictures or (b) fistulas were evaluated and compared with biopsies from patients with non-stricturing/non-penetrating disease.

Results

Five histomorphological parameters demonstrated significant associations to different disease courses when applying univariate analysis. In a multivariate logistic regression model (1) severe lymphocytic infiltration of the lamina propria, (2) presence of crypt atrophy, and (3) absence of lymphocytic infiltration of the epithelium are the best variables to predict an uncomplicated disease course (Nagelkerke R2=0.329; P=0.001). The combination of these parameters has a sensitivity of 67% and a specificity of 83% to predict non-stricturing/non-penetrating disease (positive predictive value=0.75).

Conclusion

Histopathological parameters may help to predict complications of CD prior to their onset. The results of this study have to be confirmed prospectively.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1.

Similar content being viewed by others

References

  1. Borley NR, Mortensen NJ, Kettlewell M, George B, Jewell D, Warren B (2001) Connective tissue changes in ileal Crohn's disease: relationship to disease phenotype and ulcer-associated cell lineage. Dis Colon Rectum 44:388–396

    CAS  PubMed  Google Scholar 

  2. Gasche C, Scholmerich J, Brynskov J, D'Haens G, Hanauer SB, Irvine EJ, Jewell DP, Rachmilewitz D, Sachar DB, Sandborn WJ, Sutherland LR (2000) A simple classification of Crohn's Disease: report of the Working Party for the World Congresses of Gastroenterology, Vienna 1998. Inflamm Bowel Dis 6:8–15

    CAS  PubMed  Google Scholar 

  3. Gelbmann CM (2000) Prediction of treatment refractoriness in ulcerative colitis and Crohn's disease—do we have reliable markers? Inflamm Bowel Dis 6:123–131

    Google Scholar 

  4. Graham MF, Diegelmann RF, Elson CO, Lindblad WJ, Gotschalk N, Gay S, Gay R (1998) Collagen content and types in the intestinal strictures of Crohn's disease. Gastroenterology 94:257–265

    Google Scholar 

  5. Hilsden RJ, Meddings JB, Hardin J, Gall DG, Sutherland LR (1999) Intestinal permeability and postheparin plasma diamine oxidase activity in the prediction of Crohn's disease relapse. Inflamm Bowel Dis 5:85–91

    CAS  PubMed  Google Scholar 

  6. Hirata I, Berrebi G, Austin LL, Keren DF, Dobbins WO (1986) Immunohistological characterization of intraepithelial and lamina propria lymphocytes in control ileum and colon and inflammatory bowel disease. Dig Dis Sci 31:593–603

    CAS  PubMed  Google Scholar 

  7. Le Berre NL, Heresbach D, Kerbaol M, Caulet S, Bretagne JF, Chaperon J, Gosselin M, Ramée MP (1995) Histological discrimination of idiopathic inflammatory bowel disease from other types of colitis. J Clin Pathol 48:749–753

    PubMed  Google Scholar 

  8. Lennard Jones JE (1989) Classification of inflammatory bowel disease. Scand J Gastroenterol 170[Suppl]:2–6

    Google Scholar 

  9. Lesage S, Zouali H, Cezard JP, Colombel JF, Belaiche J, Almer S, Tysk C, O'Morain C, Gassull M, Binder V, Finkel Y, Modigliani R, Gower-Rousseau C, Macry J, Merlin F, Chamaillard M, Jannot AS, Thomas G, Hugot JP (2002) CARD15/NOD2 mutational analysis and genotype-phenotype correlation in 612 patients with inflammatory bowel disease. Am J Hum Genet 70:845–857

    Article  CAS  PubMed  Google Scholar 

  10. McAlindon ME, Gray T, Galvin A, Sewell HF, Podolsky DK, Mahida YR (1998) Differential lamina propria cell migration via basement membrane pores of inflammatory bowel disease mucosa. Gastroenterology 115:841–848

    CAS  PubMed  Google Scholar 

  11. Modigliani R and the GETAID group (1990) Clinical, biological and endoscopic picture of attacks of Crohn's disease. Gastroenterology 98:811–818

    CAS  PubMed  Google Scholar 

  12. Riddell RH, Goldman H, Ransohoff DF, Appelman HD, Fenaglio CM, Haggitt RC, Ahren C, Correa P, Hamilton SR, Morson BC (1983) Dysplasia in inflammatory bowel disease: standardized classification with provisional clinical applications. Hum Pathol 14:931–968

    CAS  PubMed  Google Scholar 

  13. Roseth AG, Aadland E, Jahnsen J, Raknerud N (1997) Assessment of disease activity in ulcerative colitis by faecal calprotectin, a novel granulocyte marker protein. Digestion 58:176–180

    CAS  PubMed  Google Scholar 

  14. Roseth AG, Fagerhol MK, Aadland E, Schonsby H (1992) Assessment of the neutrophil dominating protein calprotectin in feces. A methodologic study. Scand J Gastroenterol 27:793–798

    CAS  PubMed  Google Scholar 

  15. Schreiber S, Nikolaus S, Hampe J, Hamling J, Koop I, Groessner B, Lochs H, Raedler A (1999) Tumor necrosis factor alpha and interleukin 1 beta in relapse of Crohn's disease. Lancet 353:459–461

    CAS  PubMed  Google Scholar 

  16. Seldenrijk CA, Morson BC, Meuwissen SG, Schipper NW, Lindeman J, Meijer CJ (1991) Histopathological evaluation of colonic mucosal biopsy specimens in chronic inflammatory bowel disease: diagnostic implications. Gut 32:1514–1520

    CAS  PubMed  Google Scholar 

  17. Senju M, Wu KC, Mahida YR, Jewell DP (1990) Two color immunofluorescence and flow cytometric analysis of lamina propria lymphocyte subsets in ulcerative colitis and Crohn's disease. Dig Dis Sci 36:1453–1458

    Google Scholar 

  18. Surawicz CM, Belic L (1984) Rectal biopsy helps to distinguish acute self-limited colitis from idiopathic inflammatory bowel disease. Gastroenterology 86:104–113

    CAS  PubMed  Google Scholar 

  19. Tanaka M, Riddell RH, Saito H, Soma Y, Hidaka H, Kudo H (1999) Morphologic criteria applicable to biopsy specimens for effective distinction of inflammatory bowel disease from other forms of colitis and of Crohn's disease from ulcerative colitis. Scand J Gastroenterol 34:55–67

    Article  CAS  PubMed  Google Scholar 

  20. Teahon K, Smethurst P, Levi A, Menzies IS, Bjarnason I (1992) Intestinal permeability in patients with Crohn's disease and their first degree relatives. Gut 33:320–323

    CAS  PubMed  Google Scholar 

  21. Tibble JA, Sigthorsson G, Bridger S, Fagerhol MK, Bjarnason I (2000) Surrogate markers of intestinal inflammation are predictive of relapse in patients with inflammatory bowel disease. Gastroenterology 119:15–22

    CAS  PubMed  Google Scholar 

  22. Wyatt J, Vogelsang H, Hubl W, Waldhoer T, Lochs H (1993) Intestinal permeability and the prediction of relapse in Crohn's disease. Lancet 341:1437–1439

    PubMed  Google Scholar 

Download references

Acknowledgement

This work was supported by the Bundesministerium für Bildung und Forschung (BMBF) Competence network "Inflammatory Bowel Disease".

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Frauke Bataille.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Bataille, F., Klebl, F., Rümmele, P. et al. Histopathological parameters as predictors for the course of Crohn's disease. Virchows Arch 443, 501–507 (2003). https://doi.org/10.1007/s00428-003-0863-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00428-003-0863-6

Keywords

Navigation